October 12, 2023
The Globe and Mail | Quebec heart technology maker OpSens bought by Haemonetics for $345-million
David Martin, Managing Director and Head of Bloom Burton Equity Research comments in The Globe and Mail regarding the OpSens (TSX:OPS) sale to Boston-based Haemonetics Corp.
